Caitlin Brandt is a senior research analyst at the Center for Health Policy at the Brookings Institution and has been at Brookings since June 2014. Her main research focuses are the implementation of the Affordable Care Act, insurer and provider market competition, and state-level policy issues.
Recent Posts by Caitlin Brandt
As networks continue to narrow, it is essential that regulators embrace a multilayered approach to network adequacy, instead of turn a blind eye to essential consumer protections.
States cannot protect more than half of commercially insured consumers due to an arcane federal law, known as the Employee Retirement Income Security Act, which exempts almost 100 million people in private insurance plans from state regulation because their plans are self-funded by employers.
A Controversial New Demonstration In Medicare: Potential Implications For Physician-Administered Drugs
Some of the most expensive drugs are covered under Medicare’s medical benefit, Part B, because they are administered by a physician. The high growth rate of Part B drug spending is a concern, especially as expensive breakthrough cancer drugs enter the market.
In April 2014, the Centers for Medicare and Medicaid (CMS) released millions of lines of Medicare Part B physician payment data, that led many researchers, analysts, journalists, and the general public to use the data to answer a number of pressing health care questions. And while the dataset...